The Wnt signaling pathway has tumor suppressor properties in retinoblastoma

Shoshana Tell, Hyun Yi, Maria Elena Jockovich, Timothy G. Murray, Abigail S Hackam

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are believed to be required for tumor initiation. Mutations in the Wnt signaling pathway have been implicated in the pathogenesis of many cancers. Multiple Wnt pathway genes are expressed in the retina and the pRb and Wnt pathways interact biochemically, raising the possibility that alterations in the Wnt pathway contribute to retinoblastoma. Our studies showed that Wnt signaling activation significantly decreased the viability of retinoblastoma cell lines by inducing cell cycle arrest, which was associated with upregulated p53. Furthermore, immunolocalization of the Wnt signaling mediator β-catenin in human and mouse retinoblastoma tissue indicated that canonical Wnt signaling is suppressed in tumors in vivo. These studies are consistent with the Wnt pathway acting as a tumor suppressor in retinoblastoma and suggest that loss of Wnt signaling is tumorigenic in the retina.

Original languageEnglish
Pages (from-to)261-269
Number of pages9
JournalBiochemical and Biophysical Research Communications
Volume349
Issue number1
DOIs
StatePublished - Oct 13 2006

Fingerprint

Wnt Signaling Pathway
Retinoblastoma
Tumors
Neoplasms
Retina
Retinal Neoplasms
Cells
Catenins
Pediatrics
Cell Cycle Checkpoints
Genes
Chemical activation
Tissue
Cell Line
Mutation

Keywords

  • β-catenin
  • Cell cycle
  • p53
  • pRb
  • RB1
  • Retinoblastoma
  • Wnt

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. / Tell, Shoshana; Yi, Hyun; Jockovich, Maria Elena; Murray, Timothy G.; Hackam, Abigail S.

In: Biochemical and Biophysical Research Communications, Vol. 349, No. 1, 13.10.2006, p. 261-269.

Research output: Contribution to journalArticle

Tell, Shoshana ; Yi, Hyun ; Jockovich, Maria Elena ; Murray, Timothy G. ; Hackam, Abigail S. / The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 349, No. 1. pp. 261-269.
@article{5f78a70eb5e04774b93ad0a9d8e5dd8c,
title = "The Wnt signaling pathway has tumor suppressor properties in retinoblastoma",
abstract = "Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are believed to be required for tumor initiation. Mutations in the Wnt signaling pathway have been implicated in the pathogenesis of many cancers. Multiple Wnt pathway genes are expressed in the retina and the pRb and Wnt pathways interact biochemically, raising the possibility that alterations in the Wnt pathway contribute to retinoblastoma. Our studies showed that Wnt signaling activation significantly decreased the viability of retinoblastoma cell lines by inducing cell cycle arrest, which was associated with upregulated p53. Furthermore, immunolocalization of the Wnt signaling mediator β-catenin in human and mouse retinoblastoma tissue indicated that canonical Wnt signaling is suppressed in tumors in vivo. These studies are consistent with the Wnt pathway acting as a tumor suppressor in retinoblastoma and suggest that loss of Wnt signaling is tumorigenic in the retina.",
keywords = "β-catenin, Cell cycle, p53, pRb, RB1, Retinoblastoma, Wnt",
author = "Shoshana Tell and Hyun Yi and Jockovich, {Maria Elena} and Murray, {Timothy G.} and Hackam, {Abigail S}",
year = "2006",
month = "10",
day = "13",
doi = "10.1016/j.bbrc.2006.08.044",
language = "English",
volume = "349",
pages = "261--269",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The Wnt signaling pathway has tumor suppressor properties in retinoblastoma

AU - Tell, Shoshana

AU - Yi, Hyun

AU - Jockovich, Maria Elena

AU - Murray, Timothy G.

AU - Hackam, Abigail S

PY - 2006/10/13

Y1 - 2006/10/13

N2 - Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are believed to be required for tumor initiation. Mutations in the Wnt signaling pathway have been implicated in the pathogenesis of many cancers. Multiple Wnt pathway genes are expressed in the retina and the pRb and Wnt pathways interact biochemically, raising the possibility that alterations in the Wnt pathway contribute to retinoblastoma. Our studies showed that Wnt signaling activation significantly decreased the viability of retinoblastoma cell lines by inducing cell cycle arrest, which was associated with upregulated p53. Furthermore, immunolocalization of the Wnt signaling mediator β-catenin in human and mouse retinoblastoma tissue indicated that canonical Wnt signaling is suppressed in tumors in vivo. These studies are consistent with the Wnt pathway acting as a tumor suppressor in retinoblastoma and suggest that loss of Wnt signaling is tumorigenic in the retina.

AB - Retinoblastoma is a pediatric retinal tumor caused by mutational inactivation of the tumor suppressor pRb. Additional genetic changes, as yet unidentified, are believed to be required for tumor initiation. Mutations in the Wnt signaling pathway have been implicated in the pathogenesis of many cancers. Multiple Wnt pathway genes are expressed in the retina and the pRb and Wnt pathways interact biochemically, raising the possibility that alterations in the Wnt pathway contribute to retinoblastoma. Our studies showed that Wnt signaling activation significantly decreased the viability of retinoblastoma cell lines by inducing cell cycle arrest, which was associated with upregulated p53. Furthermore, immunolocalization of the Wnt signaling mediator β-catenin in human and mouse retinoblastoma tissue indicated that canonical Wnt signaling is suppressed in tumors in vivo. These studies are consistent with the Wnt pathway acting as a tumor suppressor in retinoblastoma and suggest that loss of Wnt signaling is tumorigenic in the retina.

KW - β-catenin

KW - Cell cycle

KW - p53

KW - pRb

KW - RB1

KW - Retinoblastoma

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=33748307553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748307553&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.08.044

DO - 10.1016/j.bbrc.2006.08.044

M3 - Article

C2 - 16930536

AN - SCOPUS:33748307553

VL - 349

SP - 261

EP - 269

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -